Selank
Typical Dosage
Intranasal: 200-400 mcg
Injection: 1 mg
Administration
Nasal • Injection
Half-Life
Minutes (plasma); extended CNS activity
Mechanism of Action
Anxiolytic and stress research|Immune-neuro interface studies|Cognition/focus models|Nasal peptide delivery
Research Protocol Summary
Evidence Level
Clinical Use / Mixed Literature
Typical Protocol Duration
8 Weeks
Species Studied
Human • Rat
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…